GR970100486A - Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης - Google Patents

Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης

Info

Publication number
GR970100486A
GR970100486A GR970100486A GR970100486A GR970100486A GR 970100486 A GR970100486 A GR 970100486A GR 970100486 A GR970100486 A GR 970100486A GR 970100486 A GR970100486 A GR 970100486A GR 970100486 A GR970100486 A GR 970100486A
Authority
GR
Greece
Prior art keywords
bambuterol
pharmaceutically acceptable
acceptable salts
formulation
particular range
Prior art date
Application number
GR970100486A
Other languages
English (en)
Other versions
GR1003207B (el
Inventor
Staffan Annefors
Carl-Axel Bauer
Hans Nilsson
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of GR970100486A publication Critical patent/GR970100486A/el
Publication of GR1003207B publication Critical patent/GR1003207B/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
GR970100486A 1996-12-20 1997-12-10 Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης GR1003207B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9604752A SE9604752D0 (sv) 1996-12-20 1996-12-20 Formulation and use

Publications (2)

Publication Number Publication Date
GR970100486A true GR970100486A (el) 1998-08-31
GR1003207B GR1003207B (el) 1999-09-14

Family

ID=20405108

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970100486A GR1003207B (el) 1996-12-20 1997-12-10 Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης

Country Status (24)

Country Link
US (1) US6075048A (el)
EP (1) EP0921795A1 (el)
JP (1) JP2001501225A (el)
KR (1) KR19990082274A (el)
CN (1) CN1210464A (el)
AU (1) AU7871398A (el)
BE (1) BE1011395A5 (el)
BR (1) BR9707574A (el)
CA (1) CA2243085A1 (el)
CZ (1) CZ243898A3 (el)
ES (1) ES2131482B1 (el)
FR (1) FR2757398B1 (el)
GR (1) GR1003207B (el)
HU (1) HUP9901792A3 (el)
ID (1) ID23693A (el)
IE (1) IE970899A1 (el)
IL (1) IL125535A0 (el)
NL (1) NL1007839C2 (el)
NO (1) NO983556L (el)
PL (1) PL328334A1 (el)
SE (1) SE9604752D0 (el)
TR (1) TR199801500T1 (el)
WO (1) WO1998027981A1 (el)
ZA (1) ZA9711047B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
CN104784106A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液的制备方法
CN104784108A (zh) * 2014-01-17 2015-07-22 南京瑞尔医药有限公司 一种盐酸班布特罗口服溶液组合物
CN110898003A (zh) * 2019-12-09 2020-03-24 岳阳新华达制药有限公司 一种新型盐酸班布特罗口服溶液及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) * 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086363A (en) * 1977-03-16 1978-04-25 Usv Pharmaceutical Corporation Treatment of asthma
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
SE9604752D0 (sv) * 1996-12-20 1996-12-20 Astra Ab Formulation and use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043807A2 (en) * 1980-07-09 1982-01-13 Aktiebolaget Draco 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations

Also Published As

Publication number Publication date
BR9707574A (pt) 1999-07-27
AU7871398A (en) 1998-07-17
FR2757398A1 (fr) 1998-06-26
HUP9901792A3 (en) 2000-04-28
NL1007839C2 (nl) 1998-08-31
IL125535A0 (en) 1999-03-12
CA2243085A1 (en) 1998-07-02
WO1998027981A1 (en) 1998-07-02
IE970899A1 (en) 1998-10-07
US6075048A (en) 2000-06-13
CZ243898A3 (cs) 1998-11-11
FR2757398B1 (fr) 2000-09-01
ZA9711047B (en) 1998-06-22
PL328334A1 (en) 1999-01-18
NO983556D0 (no) 1998-08-03
SE9604752D0 (sv) 1996-12-20
KR19990082274A (ko) 1999-11-25
ID23693A (id) 2000-05-11
TR199801500T1 (xx) 1999-02-22
BE1011395A5 (fr) 1999-08-03
GR1003207B (el) 1999-09-14
NL1007839A1 (nl) 1998-06-23
NO983556L (no) 1998-08-03
JP2001501225A (ja) 2001-01-30
HUP9901792A2 (hu) 1999-10-28
ES2131482A1 (es) 1999-07-16
CN1210464A (zh) 1999-03-10
ES2131482B1 (es) 2000-03-01
EP0921795A1 (en) 1999-06-16

Similar Documents

Publication Publication Date Title
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
ATE239482T1 (de) Neue arzneiformulierung
CA2268886A1 (en) Aminothiophenecarboxamides
MY132705A (en) Novel compounds with analgesic effect
TR26721A (tr) Jel tipi kozmetik bilesimler
EP0413953A3 (en) Copolymer as thickening agent in aqueous preparations active at a ph 5,5, process of its preparation and its use as thickening agent
AU2490297A (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
GB9613003D0 (en) N-oxides of morpholine derivatives and their use as therapeutic agents
GB9423911D0 (en) Therapeutic agents
GR970100333A (el) Φαρμακευτικα παρασκευασματα για ενδορρινικη χορηγηση
PL318132A1 (en) Aqueous preparations of risperidone
GB0214845D0 (en) Pharmaceutical formulations containing zolmitriptan
BG103325A (en) Analgetic preparation for external application
AU2001289606A1 (en) Dry powder formulation comprising racecadotril
CA2222698A1 (fr) Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
PH31320A (en) Fenbendazole formulations.
GR1003207B (el) Νεοι φαρμακευτικοι σχηματισμοι και χρησεις βαμβουτερολης
GB8913529D0 (en) Nitrogen-containing derivatives of carboxymethylcellulose,their preparation and their use in cosmetic formulations
AU571205B2 (en) Pyrethroid pharmaceutical composition
WO1999038506A3 (en) Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
ZA911434B (en) Water soluble salts of purpuromycin and pharmaceutical formulations thereof
GB2219586B (en) Derivatives of carboxymethylcellulose containing betaine groups,their preparation and their use in cosmetic formulations
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
FI940185A (fi) 4-pyrimidinonijohdannaisten suoloja, niiden valmistus ja niiden käyttö terapiassa

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees